LGMN and Alzheimer disease: Activation of C/EBPβ triggers AEP‐mediated cleavage of APP N585 and tau N368, promoting Aβ production and tau hyperphosphorylation, thereby inducing neuroinflammation and neurotoxicity, which drive AD pathogenesis [11, 12, 13].